Trial intelligence / Profile preview

Phase II study of PSO17J intra-articular injection in knee osteoarthritis

jRCT2011260040Phase 2Recruiting

Start
Sep 2026
Countries
1
01

Overview

Phase 2, open-label trial in knee osteoarthritis (OA) (2 arms), sponsored by none. Primary endpoint: Safety. Started Sep 2026; status: recruiting.

02

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on jRCT2011260040.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2011260040.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call